Navigation Links
FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone
Date:8/23/2009

SEATTLE, Aug. 24 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.

"The FDA's acceptance to file our pixantrone NDA represents a significant milestone for CTI and for patients with relapsed and refractory aggressive NHL. We look forward to working with the FDA and their final decision on our request for priority review," noted James Bianco, M.D., Chief Executive Officer of CTI.

About Pixantrone

Pixantrone (BBR 2778), is a novel topoisomerase II inhibitor with an aza-anthracenedione molecular structure that differentiates it from currently marketed anthracyclines and other related chemotherapy agents. Anthracyclines are the cornerstone therapeutic for the treatment of lymphoma, leukemia, and breast cancer. Although anthracyclines are sufficiently effective to be used as first-line (initial) treatment, anthracyclines cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of anthracycline doses and most patients who previously have been treated with an anthracycline are not able to receive further anthracycline treatment if the patient's disease returns. Pixantrone also can be administered through a peripheral vein rather than a central implanted catheter as required for other drugs in this class. The FDA is required to set an action date for review of an application 74 days after the initial submission of the NDA. CTI expects to receive the action date for this drug candidate from the FDA and a
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Accepts Drug Application for Miconazole Lauriad(R) to Treat Oropharyngeal Candidiasis
2. Erik Estrada Accepts Honorary Appointment from Project Lifesaver International
3. House Energy & Commerce Committee Accepts Independence at Home Pilot Program as Amendment During Health Bill Markup
4. FDA Accepts Tris Pharmas ANDA with Paragraph IV Certification for a Generic Equivalent to Delsym
5. Victory Pharma, Inc. Announces FDA Accepts MGX006 NDA for Review
6. Specialty Hospitals of America Accepts First Patients in New Long Term Critical Care Hospital Located in South East Washington
7. FDA Accepts Final Section of NDA Filing for LUCASSIN(R)
8. NYSE Amex Accepts China Shenghuos Compliance Plan for Continued Listing
9. NYSE Amex LLC Accepts Plan of Compliance of The Quantum Group, Inc.
10. United States Patent and Trademark Office Accepts CoolTouch's Re-examination Request for Cynosure '873 Patent
11. NYSE Amex Accepts Interleukin Genetics Plan to Meet Continued Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... ... Dignity Health named Dr. Norris A. Baldwin, Jr. the Facility Medical Director ... August. The new facility is licensed under Dignity Health Arizona General Hospital ... is an excellent leader and will ensure our new freestanding emergency room delivers the ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Constantin Vasilica, 48 ... by tissue injury caused by diabetes after many years of suffering and using medications ... and he didn’t want to ask for extra time off or wait longer hours ...
(Date:8/3/2015)... ... August 03, 2015 , ... Foot and Ankle Specialists of the ... creating the largest medical practice in the Mid-Atlantic region – and the second largest ... locations with 33 doctors. , Dr. Hetal Kathrotiya-Mago is a Maryland native. She grew ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... Code Council (ICC) announce an agreement to collaborate across a wide range ... to increasing building code knowledge among architects. , “Our combined membership, consisting of ...
(Date:8/3/2015)... ... 03, 2015 , ... Recent reports by the American Medical Association show that ... their lives. Often time, low back and sciatic pain can happen as a result ... clinically with powerful pain medication or spinal surgery. Dynamic Health Care in Louisville, ...
Breaking Medicine News(10 mins):Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 3Health News:Dynamic Health Care in Louisville, KY, Offers a New and Cutting-Edge Therapy for Low Back & Leg Pain Sufferers 2
... with diabetes are sexually active according to a study of ... September 2010 issue of the journal Diabetes Care . ... percent of partnered women with diabetes engaged in sexual activity ... diabetes, the study showed. The disease took a toll, ...
... difficile, a wily, familiar bacterium, causes a growing number ... a $7.5 million, five-year award from the National Institutes of ... in the microbe and in patients make C. difficile ... nearly a half-million Americans each year. ,U-M scientists and clinicians ...
... stay sober for several decades. It interferes with the body,s ... who consumes even a small amount of alcohol. More ... addiction as well, even though alcohol and cocaine affect the ... Emory University School of Medicine have identified how disulfiram may ...
... a small and cheap-to-build unmanned aerial vehicle (UAV) intended ... reduce risks to material and human lives. The seaplane ... plane to fly in severe weather conditions. The resulting ... payload of up to 40 kg. It is equipped ...
... Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Aug. 25 ... the economic recession in 2008, nearly one in four American ... inadequate they were unable to access the medical care their ... special needs were more likely than others to say their ...
... may potentially play an important role in treating ... disabling diseasethe Society of Interventional Radiology has issued ... clinical research to determine the safety and effectiveness ... endorsed by the Canadian Interventional Radiology Association and ...
Cached Medicine News:Health News:Diabetes impairs but does not halt sex among older adults 2Health News:Diabetes impairs but does not halt sex among older adults 3Health News:U-M launches effort to conquer common hospital-acquired infection 2Health News:Experimental treatments for cocaine addiction may prevent relapse 2Health News:Shape-shifting robot plane offers safer alternative for maritime rescue 2Health News:Shape-shifting robot plane offers safer alternative for maritime rescue 3Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 2Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 3Health News:Society of Interventional Radiology supports research for new MS treatments 2Health News:Society of Interventional Radiology supports research for new MS treatments 3
(Date:8/3/2015)... N.J. , Aug. 3, 2015  Celsion ... the Company will host a conference call to ... provide an update on its development programs for ... and two newly acquired technology platforms, TheraPlas™ and ... a.m. EDT on Monday, August 10, 2015. To ...
(Date:8/3/2015)... -- Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: IMNP ), ... will present live at VirtualInvestorConferences.com on August 6, 2015. ... EDT LINK:    http://tinyurl.com/aug6-pre-imnp This ... are invited to ask the company questions in real-time ... the association,s "virtual trade booth." If attendees are not ...
(Date:8/3/2015)... BOULDER, Colo., Aug. 3, 2015  Encision Inc. (PK:ECIA), ... prevents dangerous stray electrosurgical burns in minimally invasive surgery, ... quarter that ended June 30, 2015. The ... a quarterly net loss of $213 thousand, or $(0.02) ... $2.476 million for a net loss of $202 thousand, ...
Breaking Medicine Technology:Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5
... is a simple, effective instrument to grasp soft ... stitch and loop. The grasping function of the ... tissue and precisely place a stitch up to ... tissue, all in one quick step. The sterile, ...
... The patented ratchet design provides fingertip ... ,The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ...
Leg holder for arthroscopy....
Irrigation pump for arthroscopy....
Medicine Products: